Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$490.01 USD

490.01
1,224,601

+7.92 (1.64%)

Updated Sep 19, 2024 04:00 PM ET

After-Market: $488.32 -1.69 (-0.34%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Here's Why Intuitive Surgical, Inc. (ISRG) Gained But Lagged the Market Today

In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $490.01, denoting a +1.64% change from the preceding trading day.

Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Intuitive Surgical (ISRG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $483.32, signifying a -1.64% move from its prior day's close.

Is Phibro Stock Worth Retaining in Your Portfolio Now?

PAHC Animal Health business, supported by the flourishing vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.

Labcorp Stock Gains From Its Latest Acquisition of BioReference Health

LH completes the acquisition of BioReference Health, a wholly-owned subsidiary of OPKO Health. The acquisition includes BioReference Health's laboratory testing businesses.

QGEN Stock Likely to Gain From Innovation Amid Competition

To support internal growth, QIAGEN invests heavily in research and development for the menu expansion of its key platforms.

DGX Stock Likely to Gain From Allina Health's Select Lab Assets Buyout

With the completion of the acquisition, Allina Health's clinic physicians will now have access to Quest Diagnostics' laboratory services.

Indrajit Bandyopadhyay headshot

ISRG Stock Rallies 14% in 3 Months: Is It Still Worth Buying?

Intuitive Surgical is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.

KIDS Stock Gains From Its New Enabling Technologies Division Launch

OrthoPediatrics recently launched its Enabling Technologies division, set to generate sustainable revenue growth and gain access to new markets and specialties beyond orthopedics.

Zacks Industry Outlook Intuitive Surgical, Masimo and Veracyte

Intuitive Surgical, Masimo and Veracyte have been highlighted in this Industry Outlook article

Zacks Investment Ideas feature highlights: Intuitive Surgical, SharkNinja and DaVita

Intuitive Surgical, SharkNinja and DaVita have been highlighted in this Investment Ideas article.

Urmimala Biswas headshot

3 Medical Instruments Industry Stocks to Buy on genAI and M&A Boost

ISRG, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar the prospects.

Derek Lewis headshot

3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN

Stocks making new highs tend to make even higher highs, particularly when positive earnings estimate revisions hit the tape. And that's precisely what these three companies have seen.

CVS Stock Gains From Its Birth Control Prescribing Service Launch

CVS Health announces that nearly 400 CVS Pharmacy locations in Massachusetts have started offering hormonal contraceptive prescribing services.

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

NARI continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.

Roche Stock to Benefit From Accu-Chek Smartguide Launch in Europe

RHHBY's Accu-Chek Smartguide will provide several predictive features aimed at enhancing patient safety. However, the device may face tough competition from existing CGM devices.

Labcorp Stock Gains From Market Expansion Efforts Amid Macro Woes

LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biopharma business.

Sanara Stock Gains From New US Distribution Deal With ChemoMouthPiece

SMTI, along with InfuSystem, inked a U.S. distribution agreement with ChemoMouthpiece. Under the agreement, ChemoMouthpiece's oral cryotherapy device will be distributed in cancer centers.

Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $490.93, signifying a +1.38% move from its prior day's close.

Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

Paragon 28 Stock Gains From the Latest Launch of Its Right-Angle Drill

FNA launched the Right-Angle Drill to enhance the APEX 3D Total Ankle Replacement System. The drill is designed to improve tibia preparation.

Reasons to Retain ResMed Stock in Your Portfolio for Now

Strong demand for RMD's market-leading mask portfolio raises investors' optimism.

The Zacks Analyst Blog Highlights Prosus, Intuitive Surgical and Unilever

Prosus, Intuitive Surgical and Unilever are included in this Analyst Blog.

John Blank headshot

August U.S. CPI Data: Global Week Ahead

Investors are on edge -- ahead of more key macro events -- that could shape the tone for trading in the weeks ahead.